NSF To Host Pharma Compliance to Performance Conference
NSF’s Compliance to Performance conference will look at two of the most pressing issues in global pharma: artificial intelligence and supply chain disruptions.
We are bringing together an exciting panel of speakers from industry, trade associations, regulatory bodies, and academia. Speakers include Martin Lush, a renowned industry veteran and globally regarded expert about AI advancements in pharma manufacturing, and Paul Fleming, Technical Director of the British Generic Manufacturers Association and British Biosimilars Association. Paul will be talking about supply chain shortages impacting the industry.
The conference will be hosted by Lynne Ensor, Senior Global Managing Director of NSF’s Pharma Biotech division. Lynne has enjoyed a long career with extensive experience, including fourteen years in senior roles with the USFDA.
The event takes place during World Quality Week and adopts the theme of Compliance to Performance.
Book your place today
Share this Article
How NSF Can Help You
What’s New with NSF
iNADO Partners with NSF to Support Members and Athletes
May 27, 2026iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation
May 20, 2026NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
NSF Annual Review and Impact Report 2025 Now Live
April 20, 2026NSF has published its Annual Review and Impact Report 2025, detailing the organization’s progress over the past year and outlining strategic priorities for 2026.
Visit NSF at Making Pharma 2026
April 10, 2026Connect with our experts to discover how we help leading pharmaceutical and biotechnology companies achieve regulatory compliance and operational excellence.